MARKET
IPO

NGIO

NUGENEREX IMMUNO-ONCOLOGY, INC.
NGIO
NASDAQ
Upcoming IPOs
Expected Listing Date: - -
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
-
Biotechnology & Medical Research
2020-09-14
Public Filing
View Prospectus
Pending
Offering
Price Range: Pending
Shares to be Issued: Pending
Pending
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 100.30M
Listed

Open & fund a brokerage account to get undefined free stocks

SIGN UP
No Data
About NGIO
More
NuGenerex Immuno-Oncology, Inc is an oncology company. The Company is focused on the modulation of the immune system to treat cancer. The Company is engaged in developing immunotherapeutic products and vaccines based on its platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) Class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. It has developed a range of Ii-Key Hybrid peptides for the immunotherapeutic targeting of tumor associated antigens (TAAs) in cancer and for vaccines against infectious diseases. It is developing AE37 for the treatment of breast cancer. AE37 is an Ii-Key-Hybrid molecule that contains the human epidermal growth factor receptor 2 (HER2)/neu antigenic peptide linked to the Ii-Key to develop immune stimulation against HER2.
Recently
Symbol
Price
%Change
    RSG
  • 247.70
  • +0.65%
    R
  • 137.82
  • -0.25%

Webull offers NUGENEREX IMMUNO-ONCOLOGY, INC. stock information, including NASDAQ: NGIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NGIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NGIO stock methods without spending real money on the virtual paper trading platform.